1
|
Smits AM, Bollini S, Gladka MM. Editorial: Novel strategies to repair the infarcted heart, volume II. Front Cardiovasc Med 2024; 11:1379240. [PMID: 38516001 PMCID: PMC10955122 DOI: 10.3389/fcvm.2024.1379240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Accepted: 02/28/2024] [Indexed: 03/23/2024] Open
Affiliation(s)
- Anke M. Smits
- Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands
| | - Sveva Bollini
- Department of Experimental Medicine (DIMES), University of Genova, Genova, Italy
- Cellular Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
| | - Monika M. Gladka
- Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, Amsterdam, Netherlands
| |
Collapse
|
2
|
Gladka MM, Johansen AKZ, van Kampen SJ, Peters MMC, Molenaar B, Versteeg D, Kooijman L, Zentilin L, Giacca M, van Rooij E. Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice. Cardiovasc Res 2023; 119:802-812. [PMID: 36125329 PMCID: PMC10153422 DOI: 10.1093/cvr/cvac155] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Revised: 07/12/2022] [Accepted: 08/09/2022] [Indexed: 11/13/2022] Open
Abstract
AIMS The adult mammalian heart is a post-mitotic organ. Even in response to necrotic injuries, where regeneration would be essential to reinstate cardiac structure and function, only a minor percentage of cardiomyocytes undergo cytokinesis. The gene programme that promotes cell division within this population of cardiomyocytes is not fully understood. In this study, we aimed to determine the gene expression profile of proliferating adult cardiomyocytes in the mammalian heart after myocardial ischaemia, to identify factors to can promote cardiac regeneration. METHODS AND RESULTS Here, we demonstrate increased 5-ethynyl-2'deoxyuridine incorporation in cardiomyocytes 3 days post-myocardial infarction in mice. By applying multi-colour lineage tracing, we show that this is paralleled by clonal expansion of cardiomyocytes in the borderzone of the infarcted tissue. Bioinformatic analysis of single-cell RNA sequencing data from cardiomyocytes at 3 days post ischaemic injury revealed a distinct transcriptional profile in cardiomyocytes expressing cell cycle markers. Combinatorial overexpression of the enriched genes within this population in neonatal rat cardiomyocytes and mice at postnatal day 12 (P12) unveiled key genes that promoted increased cardiomyocyte proliferation. Therapeutic delivery of these gene cocktails into the myocardial wall after ischaemic injury demonstrated that a combination of thymosin beta 4 (TMSB4) and prothymosin alpha (PTMA) provide a permissive environment for cardiomyocyte proliferation and thereby attenuated cardiac dysfunction. CONCLUSION This study reveals the transcriptional profile of proliferating cardiomyocytes in the ischaemic heart and shows that overexpression of the two identified factors, TMSB4 and PTMA, can promote cardiac regeneration. This work indicates that in addition to activating cardiomyocyte proliferation, a supportive environment is a key for regeneration to occur.
Collapse
Affiliation(s)
- Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Anne Katrine Z Johansen
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Sebastiaan J van Kampen
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Marijn M C Peters
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
- Department of Cardiology, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, The Netherlands
| | - Bas Molenaar
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Danielle Versteeg
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Lieneke Kooijman
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Lorena Zentilin
- AAV Vector Unit, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy
| | - Mauro Giacca
- School of Cardiovascular Medicine and Science, King’s College London, London, United Kingdom
| | - Eva van Rooij
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
- Department of Cardiology, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, The Netherlands
| |
Collapse
|
3
|
Gladka MM, van der Velden J. Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy. Cardiovasc Res 2023; 119:e131-e132. [PMID: 37102235 DOI: 10.1093/cvr/cvad049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/28/2023] Open
Affiliation(s)
- Monika M Gladka
- Department of Medical Biology, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands
| | - Jolanda van der Velden
- Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, Location VUmc, O2 Science building, De Boelelaan 1108, 1081HZ Amsterdam, The Netherlands
| |
Collapse
|
4
|
Gladka MM, Le Couteur DG, Simpson SJ. Midnight snacks might shorten your life: lifespan and healthspan advantages of eating less and at the right time. Cardiovasc Res 2023; 119:e108-e110. [PMID: 36690382 DOI: 10.1093/cvr/cvad018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Accepted: 01/05/2023] [Indexed: 01/25/2023] Open
Affiliation(s)
- Monika M Gladka
- Department of Medical Biology, Amsterdam University Medical Center, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
| | - David G Le Couteur
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
- Faculty of Science, School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales, Australia
| | - Stephen J Simpson
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
- Faculty of Science, School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales, Australia
| |
Collapse
|
5
|
Bollini S, Gladka MM, Smits AM. Editorial: Straight from the heart: Novel insights and future perspectives for cardiac repair. Front Cardiovasc Med 2023. [PMID: 36865884 PMCID: PMC9972076 DOI: 10.3389/fcvm.2023.1149626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
Affiliation(s)
- Sveva Bollini
- Department of Experimental Medicine (DIMES), University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy
| | - Monika M. Gladka
- Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, Amsterdam, Netherlands,*Correspondence: Monika M. Gladka ✉
| | - Anke M. Smits
- Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands
| |
Collapse
|
6
|
Gladka MM, Johansen AKZ, van Kampen SJ, Peters MMC, Molenaar B, Versteeg D, Kooijman L, Zentilin L, Giacca M, van Rooij E. Thymosin β4 and prothymosin α promote cardiac regeneration post-ischemic injury in mice. Cardiovasc Res 2022. [PMID: 36125329 DOI: 10.1093/cvr/cvac139launch] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/23/2023] Open
Abstract
The adult mammalian heart is a post-mitotic organ. Even in response to necrotic injuries, where regeneration would be essential to reinstate cardiac structure and function, only a minor percentage of cardiomyocytes undergo cytokinesis. The gene program that promotes cell division within this population is not fully understood. Here, we demonstrate increased EdU incorporation in cardiomyocytes at 3 days post-myocardial infarction (MI) in mice. By applying multi-color lineage tracing, we show that this is paralleled by clonal expansion of cardiomyocytes in the borderzone of the infarcted tissue. Bioinformatic analysis of single-cell RNA sequencing (scRNA-seq) data from cardiomyocytes at 3 days post ischemic injury revealed a distinct transcriptional profile in cardiomyocytes expressing cell cycle markers. Combinatorial overexpression of the enriched genes within this population in neonatal rat cardiomyocytes (NRCM) and mice at postnatal day 12 (P12) unveiled key genes that promoted increased cardiomyocyte proliferation. Therapeutic delivery of these gene cocktails into the myocardial wall after ischemic injury demonstrated that a combination of thymosin beta 4 (TMSB4) and prothymosin alpha (PTMA) provide a permissive environment for cardiomyocyte proliferation and thereby attenuated cardiac dysfunction. This work indicates that in addition to activating cardiomyocyte proliferation, a supportive environment is key for regeneration to occur.
Collapse
Affiliation(s)
- Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
- Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Anne Katrine Z Johansen
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
- Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Sebastiaan J van Kampen
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Marijn M C Peters
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
- Department of Cardiology, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, The Netherlands
| | - Bas Molenaar
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Danielle Versteeg
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Lieneke Kooijman
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
| | - Lorena Zentilin
- AAV Vector Unit, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy
| | - Mauro Giacca
- School of Cardiovascular Medicine and Science, King's College London, London, United Kingdom
| | - Eva van Rooij
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands
- Department of Cardiology, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, The Netherlands
| |
Collapse
|
7
|
Gladka MM, Christoffels VM. Studying the role of chromatin organization in cardiovascular diseases: future perspectives. Cardiovasc Res 2021; 117:e156-e158. [PMID: 34613365 DOI: 10.1093/cvr/cvab319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Monika M Gladka
- Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Vincent M Christoffels
- Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| |
Collapse
|
8
|
Gladka MM, Baker AH. Jumping on base editing to repair the diseased cardiovascular system in vivo. Cardiovasc Res 2021; 117:e46-e48. [PMID: 33749783 DOI: 10.1093/cvr/cvab057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, PO Box 85164, 3508 AD Utrecht, The Netherlands
| | - Andrew H Baker
- Centre for Cardiovascular Science, Queens Medical Research Institute, 47 Little France Crescent, University of Edinburgh, Edinburgh EH16 4TJ, UK
| |
Collapse
|
9
|
Gladka MM, Pasterkamp G. Scientists on the Spot: Re-defining atherosclerosis through biobanks. Cardiovasc Res 2021; 117:e99-e100. [PMID: 34179951 DOI: 10.1093/cvr/cvab090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Monika M Gladka
- Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Gerard Pasterkamp
- Laboratory of Experimental Cardiology and Clinical Chemistry, University Medical Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
10
|
Vigil-Garcia M, Demkes CJ, Eding JEC, Versteeg D, de Ruiter H, Perini I, Kooijman L, Gladka MM, Asselbergs FW, Vink A, Harakalova M, Bossu A, van Veen TAB, Boogerd CJ, van Rooij E. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling. Cardiovasc Res 2021; 117:1532-1545. [PMID: 32717063 PMCID: PMC8152696 DOI: 10.1093/cvr/cvaa233] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 05/15/2020] [Accepted: 07/22/2020] [Indexed: 01/30/2023] Open
Abstract
AIMS Pathological cardiac remodelling is characterized by cardiomyocyte (CM) hypertrophy and fibroblast activation, which can ultimately lead to maladaptive hypertrophy and heart failure (HF). Genome-wide expression analysis on heart tissue has been instrumental for the identification of molecular mechanisms at play. However, these data were based on signals derived from all cardiac cell types. Here, we aimed for a more detailed view on molecular changes driving maladaptive CM hypertrophy to aid in the development of therapies to reverse pathological remodelling. METHODS AND RESULTS Utilizing CM-specific reporter mice exposed to pressure overload by transverse aortic banding and CM isolation by flow cytometry, we obtained gene expression profiles of hypertrophic CMs in the more immediate phase after stress, and CMs showing pathological hypertrophy. We identified subsets of genes differentially regulated and specific for either stage. Among the genes specifically up-regulated in the CMs during the maladaptive phase we found known stress markers, such as Nppb and Myh7, but additionally identified a set of genes with unknown roles in pathological hypertrophy, including the platelet isoform of phosphofructokinase (PFKP). Norepinephrine-angiotensin II treatment of cultured human CMs induced the secretion of N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) and recapitulated the up-regulation of these genes, indicating conservation of the up-regulation in failing CMs. Moreover, several genes induced during pathological hypertrophy were also found to be increased in human HF, with their expression positively correlating to the known stress markers NPPB and MYH7. Mechanistically, suppression of Pfkp in primary CMs attenuated stress-induced gene expression and hypertrophy, indicating that Pfkp is an important novel player in pathological remodelling of CMs. CONCLUSION Using CM-specific transcriptomic analysis, we identified novel genes induced during pathological hypertrophy that are relevant for human HF, and we show that PFKP is a conserved failure-induced gene that can modulate the CM stress response.
Collapse
MESH Headings
- Animals
- Cardiac Myosins/genetics
- Cardiac Myosins/metabolism
- Cardiomegaly/genetics
- Cardiomegaly/metabolism
- Cardiomegaly/pathology
- Cardiomegaly/physiopathology
- Cells, Cultured
- Disease Models, Animal
- Fibrosis
- Gene Expression Profiling
- Gene Expression Regulation
- Humans
- Male
- Mice, Inbred C57BL
- Mice, Transgenic
- Myocytes, Cardiac/metabolism
- Myocytes, Cardiac/pathology
- Myosin Heavy Chains/genetics
- Myosin Heavy Chains/metabolism
- Natriuretic Peptide, Brain/genetics
- Natriuretic Peptide, Brain/metabolism
- Phosphofructokinase-1, Type C/genetics
- Phosphofructokinase-1, Type C/metabolism
- Transcriptome
- Ventricular Remodeling/genetics
- Mice
Collapse
Affiliation(s)
- Marta Vigil-Garcia
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Charlotte J Demkes
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
- Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Joep E C Eding
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Danielle Versteeg
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Hesther de Ruiter
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Ilaria Perini
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Lieneke Kooijman
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Folkert W Asselbergs
- Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands
- Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK
- Health Data Research UK and Institute of Health Informatics, University College London, London, UK
| | - Aryan Vink
- Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Magdalena Harakalova
- Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Alexander Bossu
- Department of Medical Physiology, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Toon A B van Veen
- Department of Medical Physiology, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Cornelis J Boogerd
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
| | - Eva van Rooij
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands
- Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands
| |
Collapse
|
11
|
Gladka MM, Giacca M. Scientists on the Spot: Re-awakening the heart's regenerative capacity. Cardiovasc Res 2021; 117:e79-e81. [PMID: 34037722 DOI: 10.1093/cvr/cvab066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Monika M Gladka
- Department of Medical Biology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
| | - Mauro Giacca
- British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, King's College London, The James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.,Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), 34134 Trieste, Italy.,Department of Medical, Surgical and Health Sciences, University of Trieste, 34149 Trieste, Italy
| |
Collapse
|
12
|
Molenaar B, Timmer LT, Droog M, Perini I, Versteeg D, Kooijman L, Monshouwer-Kloots J, de Ruiter H, Gladka MM, van Rooij E. Single-cell transcriptomics following ischemic injury identifies a role for B2M in cardiac repair. Commun Biol 2021; 4:146. [PMID: 33514846 PMCID: PMC7846780 DOI: 10.1038/s42003-020-01636-3] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Accepted: 12/22/2020] [Indexed: 12/11/2022] Open
Abstract
The efficiency of the repair process following ischemic cardiac injury is a crucial determinant for the progression into heart failure and is controlled by both intra- and intercellular signaling within the heart. An enhanced understanding of this complex interplay will enable better exploitation of these mechanisms for therapeutic use. We used single-cell transcriptomics to collect gene expression data of all main cardiac cell types at different time-points after ischemic injury. These data unveiled cellular and transcriptional heterogeneity and changes in cellular function during cardiac remodeling. Furthermore, we established potential intercellular communication networks after ischemic injury. Follow up experiments confirmed that cardiomyocytes express and secrete elevated levels of beta-2 microglobulin in response to ischemic damage, which can activate fibroblasts in a paracrine manner. Collectively, our data indicate phase-specific changes in cellular heterogeneity during different stages of cardiac remodeling and allow for the identification of therapeutic targets relevant for cardiac repair.
Collapse
Affiliation(s)
- Bas Molenaar
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Louk T Timmer
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Marjolein Droog
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Ilaria Perini
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Danielle Versteeg
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
- Department of Cardiology, University Medical Centre, Utrecht, The Netherlands
| | - Lieneke Kooijman
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Jantine Monshouwer-Kloots
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Hesther de Ruiter
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Eva van Rooij
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands.
- Department of Cardiology, University Medical Centre, Utrecht, The Netherlands.
| |
Collapse
|
13
|
Gladka MM, Kohela A, Molenaar B, Versteeg D, Kooijman L, Monshouwer-Kloots J, Kremer V, Vos HR, Huibers MMH, Haigh JJ, Huylebroeck D, Boon RA, Giacca M, van Rooij E. Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner. Nat Commun 2021; 12:84. [PMID: 33398012 PMCID: PMC7782784 DOI: 10.1038/s41467-020-20361-3] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Accepted: 11/20/2020] [Indexed: 12/25/2022] Open
Abstract
The disruption in blood supply due to myocardial infarction is a critical determinant for infarct size and subsequent deterioration in function. The identification of factors that enhance cardiac repair by the restoration of the vascular network is, therefore, of great significance. Here, we show that the transcription factor Zinc finger E-box-binding homeobox 2 (ZEB2) is increased in stressed cardiomyocytes and induces a cardioprotective cross-talk between cardiomyocytes and endothelial cells to enhance angiogenesis after ischemia. Single-cell sequencing indicates ZEB2 to be enriched in injured cardiomyocytes. Cardiomyocyte-specific deletion of ZEB2 results in impaired cardiac contractility and infarct healing post-myocardial infarction (post-MI), while cardiomyocyte-specific ZEB2 overexpression improves cardiomyocyte survival and cardiac function. We identified Thymosin β4 (TMSB4) and Prothymosin α (PTMA) as main paracrine factors released from cardiomyocytes to stimulate angiogenesis by enhancing endothelial cell migration, and whose regulation is validated in our in vivo models. Therapeutic delivery of ZEB2 to cardiomyocytes in the infarcted heart induces the expression of TMSB4 and PTMA, which enhances angiogenesis and prevents cardiac dysfunction. These findings reveal ZEB2 as a beneficial factor during ischemic injury, which may hold promise for the identification of new therapies.
Collapse
Affiliation(s)
- Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Arwa Kohela
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Bas Molenaar
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Danielle Versteeg
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
- Department of Cardiology, University Medical Center, Utrecht, The Netherlands
| | - Lieneke Kooijman
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Jantine Monshouwer-Kloots
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands
| | - Veerle Kremer
- Department of Physiology, Amsterdam University Medical Center VU, Amsterdam, The Netherlands
- Department of Medical Biochemistry, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Harmjan R Vos
- Molecular Cancer Research, Center for Molecular Medicine, University Medical Center, Utrecht, The Netherlands
| | - Manon M H Huibers
- Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Jody J Haigh
- Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Canada
| | - Danny Huylebroeck
- Department of Cell Biology, Erasmus University Medical Centre, Rotterdam, The Netherlands
- Department of Development and Regeneration, University of Leuven, Leuven, Belgium
| | - Reinier A Boon
- Department of Physiology, Amsterdam University Medical Center VU, Amsterdam, The Netherlands
- Institute for Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany
- German Center for Cardiovascular Research (DZHK), Frankfurt am Main, Germany
| | - Mauro Giacca
- School of Cardiovascular Medicine and Sciences, King's College London, London, UK
| | - Eva van Rooij
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, The Netherlands.
- Department of Cardiology, University Medical Center, Utrecht, The Netherlands.
| |
Collapse
|
14
|
Affiliation(s)
- Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, PO box 85164, 3508 AD, Utrecht, The Netherlands
| | - Christoph Maack
- Department of Translational Research, Comprehensive Heart Failure Center, Am Schwarzenberg 15, 97078 Würzburg, Germany.,Department of Internal Medicine I, University Clinic Würzburg, Josef-Schneider-Straße 2, 97080 Würzburg, Germany
| |
Collapse
|
15
|
Hoes MF, Te Riele ASJM, Gladka MM, Westenbrink BD, van Hout GPJ, van den Hoogenhof MMG, Ghigo A, Bollini S, Purcell NH, Sohaib SMA, Kardys I, Kuster DWD. Young@Heart: empowering the next generation of cardiovascular researchers. Neth Heart J 2020; 28:25-30. [PMID: 32780328 PMCID: PMC7418282 DOI: 10.1007/s12471-020-01454-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
In recognition of the increasing health burden of cardiovascular disease, the Dutch CardioVascular Alliance (DCVA) was founded with the ambition to lower the cardiovascular disease burden by 25% in 2030. To achieve this, the DCVA is a platform for all stakeholders in the cardiovascular field to align policies, agendas and research. An important goal of the DCVA is to guide and encourage young researchers at an early stage of their careers in order to help them overcome challenges and reach their full potential. Young@Heart is part of the DCVA that supports the young cardiovascular research community. This article illustrates the challenges and opportunities encountered by young cardiovascular researchers in the Netherlands and highlights Young@Heart’s vision to benefit from these opportunities and optimise collaborations to contribute to lowering the cardiovascular disease burden together as soon as possible.
Collapse
Affiliation(s)
- M F Hoes
- Young@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - A S J M Te Riele
- Young@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands
- Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - M M Gladka
- Young@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands
- Hubrecht Institute, Royal Netherlands Academy of Arts and Science, Utrecht, The Netherlands
- European Society of Cardiology, Scientists of Tomorrow, Biot, France
| | - B D Westenbrink
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - G P J van Hout
- Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
- Junior Chamber Board of the Netherlands Society of Cardiology, Utrecht, The Netherlands
| | - M M G van den Hoogenhof
- Institute of Experimental Cardiology, University of Heidelberg, Heidelberg, Germany
- Partner Site Heidelberg/Mannheim, DZHK (German Center for Cardiovascular Research), Heidelberg/Mannheim, Germany
| | - A Ghigo
- Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy
- International Society of Heart Research, Durham, NC, USA
| | - S Bollini
- European Society of Cardiology, Scientists of Tomorrow, Biot, France
- Department of Experimental Medicine (DIMES), Regenerative Medicine Laboratory, University of Genova, Genova, Italy
| | - N H Purcell
- Basic Cardiovascular Sciences Early Career Committee, American Heart Association, Dallas, TX, USA
- Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA, USA
| | - S M A Sohaib
- European Society of Cardiology Board Committee for Young Cardiovascular Professionals, Biot, France
- King George Hospital, Essex, UK
- St Bartholomew's Hospital, London, UK
| | - I Kardys
- Young@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands
- Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - D W D Kuster
- Young@Heart, the Dutch CardioVascular Alliance, Utrecht, The Netherlands.
- Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
| |
Collapse
|
16
|
Affiliation(s)
- Monika M Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, PO Box 85164, 3508 AD Utrecht, The Netherlands
| |
Collapse
|
17
|
Vigil-Garcia M, Demkes CJ, Eding JE, Versteeg D, de Ruiter H, Gladka MM, Harakalova M, Bossu A, Vink A, Asselbergs FW, van Veen T, van Rooij E. Abstract 262: Gene Expression Profiling of Hypertrophic and Failing Cardiomyocytes Identifies New Players Involved in Heart Failure. Circ Res 2019. [DOI: 10.1161/res.125.suppl_1.262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Pathological remodeling during cardiac disease is a detrimental response characterized by cardiomyocyte hypertrophy and fibroblast activation, which can ultimately lead to heart failure. Genome wide expression analysis on full heart tissue have been instrumental for the identification of molecular mechanisms at play. However, these data so far were based on signals derived from all cardiac cell types and a more specific view on molecular changes driving cardiomyocyte hypertrophy and failure could aid in the development of therapies aimed at improving maladaptive remodeling. Here, we generated a cardiomyocyte-specific reporter mouse (Myh6-Cre-tdTomato) that we exposed to pressure overload by transverse aortic banding (TAB). Using Fluorescence-activated Cell Sorting (FACS) we collected both hypertrophic (one week after TAB) and failing (eight weeks after TAB) cardiomyocytes. Using these cells, we performed RNA-seq and obtained subsets of genes and pathways differentially regulated and specific for either the hypertrophic or failing stages. Among these upregulated genes we identified known marker genes for cardiomyocyte failure, such as Nppb and Myh7, but also identified genes that so far have not been linked to a failing state. RNA-seq on failing and healthy human heart samples confirmed the increased expression for several of these genes regulated during cardiomyocyte failure and allowed us to show an expressional correlation to NPPB/MYH7. Moreover, we could recapitulate the upregulation of these novel genes in stressed human induced-pluripotent stem cell (iPSC)-derived cardiomyocytes. We discovered that phosphofructokinase-platelet (PFKP) protein, a glycolytic enzyme, is strongly induced in human failing cardiomyocytes. Currently, ongoing studies are focused on defining the functional relevance of the novel failure related genes in stressed iPS-derived cardiomyocytes. Our findings suggest that cardiomyocyte-specific transcriptomic analysis allows for the identification of hypertrophic and failing gene expression profiles and helps to unveil novel genes relevant for heart disease.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Alex Bossu
- Univ Med Cntr Utrecht, Utrecht, Netherlands
| | - Aryan Vink
- Univ Med Cntr Utrecht, Utrecht, Netherlands
| | | | | | | |
Collapse
|
18
|
Gladka MM, Molenaar B, de Ruiter H, van der Elst S, Tsui H, Versteeg D, Lacraz GP, Huibers MM, van Oudenaarden A, van Rooij E. Single-Cell Sequencing of the Healthy and Diseased Heart Reveals Cytoskeleton-Associated Protein 4 as a New Modulator of Fibroblasts Activation. Circulation 2018; 138:166-180. [DOI: 10.1161/circulationaha.117.030742] [Citation(s) in RCA: 164] [Impact Index Per Article: 27.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/10/2017] [Accepted: 07/01/2018] [Indexed: 11/16/2022]
Abstract
Background:
Genome-wide transcriptome analysis has greatly advanced our understanding of the regulatory networks underlying basic cardiac biology and mechanisms driving disease. However, so far, the resolution of studying gene expression patterns in the adult heart has been limited to the level of extracts from whole tissues. The use of tissue homogenates inherently causes the loss of any information on cellular origin or cell type-specific changes in gene expression. Recent developments in RNA amplification strategies provide a unique opportunity to use small amounts of input RNA for genome-wide sequencing of single cells.
Methods:
Here, we present a method to obtain high-quality RNA from digested cardiac tissue from adult mice for automated single-cell sequencing of both the healthy and diseased heart.
Results:
After optimization, we were able to perform single-cell sequencing on adult cardiac tissue under both homeostatic conditions and after ischemic injury. Clustering analysis based on differential gene expression unveiled known and novel markers of all main cardiac cell types. Based on differential gene expression, we could identify multiple subpopulations within a certain cell type. Furthermore, applying single-cell sequencing on both the healthy and injured heart indicated the presence of disease-specific cell subpopulations. As such, we identified cytoskeleton-associated protein 4 as a novel marker for activated fibroblasts that positively correlates with known myofibroblast markers in both mouse and human cardiac tissue. Cytoskeleton-associated protein 4 inhibition in activated fibroblasts treated with transforming growth factor β triggered a greater increase in the expression of genes related to activated fibroblasts compared with control, suggesting a role of cytoskeleton-associated protein 4 in modulating fibroblast activation in the injured heart.
Conclusions:
Single-cell sequencing on both the healthy and diseased adult heart allows us to study transcriptomic differences between cardiac cells, as well as cell type-specific changes in gene expression during cardiac disease. This new approach provides a wealth of novel insights into molecular changes that underlie the cellular processes relevant for cardiac biology and pathophysiology. Applying this technology could lead to the discovery of new therapeutic targets relevant for heart disease.
Collapse
Affiliation(s)
- Monika M. Gladka
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
| | - Bas Molenaar
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
| | - Hesther de Ruiter
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
| | - Stefan van der Elst
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
| | - Hoyee Tsui
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
| | - Danielle Versteeg
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
- Department of Cardiology (D.V., E.v.R.)
| | - Grègory P.A. Lacraz
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
| | - Manon M.H. Huibers
- Department of Pathology (M.M.H.), University Medical Centre, Utrecht, The Netherlands
| | | | - Eva van Rooij
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (M.M.G., B.M., H.d.R., S.v.d.E., H.T., D.V., G.P.A.L., A.v.O., E v.R.)
- Department of Cardiology (D.V., E.v.R.)
| |
Collapse
|
19
|
Gladka MM, Molenaar B, De Ruiter H, Versteeg D, Tsui H, Lacraz GPA, Van Der Elst S, Huibers MMH, Van Oudenaarden A, Van Rooij E. 239Single-cell sequencing of the healthy and diseased heart reveals Ckap4 as a new modulator of fibroblasts activation. Cardiovasc Res 2018. [DOI: 10.1093/cvr/cvy060.167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M M Gladka
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| | - B Molenaar
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| | - H De Ruiter
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| | - D Versteeg
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| | - H Tsui
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| | - GPA Lacraz
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| | - S Van Der Elst
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| | - MMH Huibers
- University Medical Center Utrecht, Utrecht, Netherlands
| | | | - E Van Rooij
- Hubrecht Institute, Molecular Cardiology, Utrecht, Netherlands
| |
Collapse
|
20
|
Lacraz GP, Junker JP, Gladka MM, Molenaar B, Scholman KT, Vigil-Garcia M, Versteeg D, de Ruiter H, Vermunt MW, Creyghton MP, Huibers MM, de Jonge N, van Oudenaarden A, van Rooij E. Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury. Circulation 2017; 136:1396-1409. [DOI: 10.1161/circulationaha.117.027832] [Citation(s) in RCA: 63] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Accepted: 07/06/2017] [Indexed: 11/16/2022]
Abstract
Background:
Cardiac ischemic injury induces a pathological remodeling response, which can ultimately lead to heart failure. Detailed mechanistic insights into molecular signaling pathways relevant for different aspects of cardiac remodeling will support the identification of novel therapeutic targets.
Methods:
Although genome-wide transcriptome analysis on diseased tissues has greatly advanced our understanding of the regulatory networks that drive pathological changes in the heart, this approach has been disadvantaged by the fact that the signals are derived from tissue homogenates. Here we used tomo-seq to obtain a genome-wide gene expression signature with high spatial resolution spanning from the infarcted area to the remote to identify new regulators of cardiac remodeling. Cardiac tissue samples from patients suffering from ischemic heart disease were used to validate our findings.
Results:
Tracing transcriptional differences with a high spatial resolution across the infarcted heart enabled us to identify gene clusters that share a comparable expression profile. The spatial distribution patterns indicated a separation of expressional changes for genes involved in specific aspects of cardiac remodeling, such as fibrosis, cardiomyocyte hypertrophy, and calcium handling (
Col1a2
,
Nppa
, and
Serca2
). Subsequent correlation analysis allowed for the identification of novel factors that share a comparable transcriptional regulation pattern across the infarcted tissue. The strong correlation between the expression levels of these known marker genes and the expression of the coregulated genes could be confirmed in human ischemic cardiac tissue samples. Follow-up analysis identified SOX9 as common transcriptional regulator of a large portion of the fibrosis-related genes that become activated under conditions of ischemic injury. Lineage-tracing experiments indicated that the majority of COL1-positive fibroblasts stem from a pool of SOX9-expressing cells, and in vivo loss of
Sox9
blunted the cardiac fibrotic response on ischemic injury. The colocalization between SOX9 and COL1 could also be confirmed in patients suffering from ischemic heart disease.
Conclusions:
Based on the exact local expression cues, tomo-seq can serve to reveal novel genes and key transcription factors involved in specific aspects of cardiac remodeling. Using tomo-seq, we were able to unveil the unknown relevance of SOX9 as a key regulator of cardiac fibrosis, pointing to SOX9 as a potential therapeutic target for cardiac fibrosis.
Collapse
Affiliation(s)
- Grégory P.A. Lacraz
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Jan Philipp Junker
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Monika M. Gladka
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Bas Molenaar
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Koen T. Scholman
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Marta Vigil-Garcia
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Danielle Versteeg
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Hesther de Ruiter
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Marit W. Vermunt
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Menno P. Creyghton
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Manon M.H. Huibers
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Nicolaas de Jonge
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Alexander van Oudenaarden
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| | - Eva van Rooij
- From Hubrecht Institute, KNAW (G.P.A.L., J.P.J., M.M.G., B.M., K.T.S., M.V.-G., D.V., H.d.R., M.W.V., M.P.C., A.v.O., E.v.R.), Department of Pathology (M.M.H.H.), Department of Cardiology (N.d.J., E.v.R.), University Medical Center Utrecht, The Netherlands; and Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (J.P.J.)
| |
Collapse
|
21
|
Affiliation(s)
- Monika M. Gladka
- From the Hubrecht Institute, KNAW and University Medical Center Utrecht, the Netherlands (M.M.G., E.v.R.); and Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands (E.v.R.)
| | - Eva van Rooij
- From the Hubrecht Institute, KNAW and University Medical Center Utrecht, the Netherlands (M.M.G., E.v.R.); and Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands (E.v.R.)
| |
Collapse
|
22
|
Dirkx E, Gladka MM, Philippen LE, Armand AS, Kinet V, Leptidis S, el Azzouzi H, Salic K, Bourajjaj M, da Silva GJJ, Olieslagers S, van der Nagel R, de Weger R, Bitsch N, Kisters N, Seyen S, Morikawa Y, Chanoine C, Heymans S, Volders PGA, Thum T, Dimmeler S, Cserjesi P, Eschenhagen T, da Costa Martins PA, De Windt LJ. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol 2013; 15:1282-93. [DOI: 10.1038/ncb2866] [Citation(s) in RCA: 112] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2013] [Accepted: 09/24/2013] [Indexed: 01/05/2023]
|
23
|
Salic K, da Costa Martins PA, Gladka MM, Leptidis S, el Azzouzi H, Hansen A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ. Abstract P192: MicroRNA-199b Targets the Nuclear Kinase Dyrk1a in an Auto-Amplification Loop Promoting Calcineurin/NFAT Signaling. Circ Res 2011. [DOI: 10.1161/res.109.suppl_1.ap192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
MicroRNAs (miRs) are a class of single-stranded, non-coding RNAs of ∼22 nucleotides in length, and growing evidence indicates that miRs are implicated in myocardial disease processes. A key pathway involved in heart failure consists of the phosphatase calcineurin and its downstream transcription factor Nuclear Factor of Activated T-cells (NFAT). We performed microRNA profiling in hearts from calcineurin transgenic mice and demonstrated that microRNA-199b (miR-199b) is a direct calcineurin/NFAT target gene. MiR-199b increases in expression in mouse and human heart failure, and targets the nuclear NFAT kinase dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a (Dyrk1a), constituting a pathogenic feed forward mechanism with impact on calcineurin-responsive gene expression. Interestingly, cardiac miR-199b levels inversely correlated with cardiac Dyrk1a expression in biopsies of failing human hearts secondary to ischemic heart disease or non-ischemic dilated cardiomyopathy. Furthermore, mutant mice overexpressing miR-199b or haploinsufficient for Dyrk1a are sensitized to calcineurin/NFAT signaling or pressure overload and exhibit stress-induced cardiomegaly by reduced Dyrk1a expression. From a therapeutic point of view, in vivo inhibition of miR-199b by a specific antagomir normalized Dyrk1a expression, reduced nuclear NFAT activity, and caused marked inhibition and even reversal of pre-established hypertrophy and fibrosis in mouse models of heart failure. Our results reveal that microRNAs impact cardiac cellular signaling and gene expression, and implicate miR-199b as a therapeutic disease target in heart failure.
Collapse
Affiliation(s)
- Kanita Salic
- Cardiovascular Rsch Institute Maastricht, Hubrecht Institute and Interuniversity Cardiology Institute Netherlands, Royal Netherlands Academy of Sciences, Maastricht, Utrecht, Netherlands
| | - Paula A da Costa Martins
- Cardiovascular Rsch Institute Maastricht, Hubrecht Institute and Interuniversity Cardiology Institute Netherlands, Royal Netherlands Academy of Sciences, Maastricht, Utrecht, Netherlands
| | - Monika M Gladka
- Cardiovascular Rsch Institute Maastricht, Maastricht, Netherlands
| | - Stefanos Leptidis
- Cardiovascular Rsch Institute Maastricht, Hubrecht Institute and Interuniversity Cardiology Institute Netherlands, Royal Netherlands Academy of Sciences, Maastricht, Utrecht, Netherlands
| | - Hamid el Azzouzi
- Cardiovascular Rsch Institute Maastricht, Hubrecht Institute and Interuniversity Cardiology Institute Netherlands, Royal Netherlands Academy of Sciences, Maastricht, Utrecht, Netherlands
| | - Arne Hansen
- Institute of Experimental and Clinical Pharmacology and Toxicology, Univ Med Cntr Hamburg-Eppendorf, Hamburg, Germany
| | - Gianluigi Condorelli
- Institute of Biomedical Technologies, Consiglio Nazionale delle Ricerche, Milan, Italy
| | - Maria L Arbones
- Cntr for Genomic Regulation and Cntr de InvestigaciÓn Biomédica en Red de Enfermedades Raras, Cntr de RegulaciÓ Genòmica, Barcelona, Spain
| | - Thomas Eschenhagen
- Institute of Experimental and Clinical Pharmacology and Toxicology, Univ Med Cntr Hamburg-Eppendorf, Hamburg, Germany
| | - Leon J De Windt
- Cardiovascular Rsch Institute Maastricht, Maastricht, Netherlands
| |
Collapse
|
24
|
da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 2010; 12:1220-7. [PMID: 21102440 DOI: 10.1038/ncb2126] [Citation(s) in RCA: 267] [Impact Index Per Article: 19.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2010] [Accepted: 11/01/2010] [Indexed: 01/01/2023]
Abstract
MicroRNAs (miRs) are a class of single-stranded, non-coding RNAs of about 22 nucleotides in length. Increasing evidence implicates miRs in myocardial disease processes. Here we show that miR-199b is a direct calcineurin/NFAT target gene that increases in expression in mouse and human heart failure, and targets the nuclear NFAT kinase dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a (Dyrk1a), constituting a pathogenic feed forward mechanism that affects calcineurin-responsive gene expression. Mutant mice overexpressing miR-199b, or haploinsufficient for Dyrk1a, are sensitized to calcineurin/NFAT signalling or pressure overload and show stress-induced cardiomegaly through reduced Dyrk1a expression. In vivo inhibition of miR-199b by a specific antagomir normalized Dyrk1a expression, reduced nuclear NFAT activity and caused marked inhibition and even reversal of hypertrophy and fibrosis in mouse models of heart failure. Our results reveal that microRNAs affect cardiac cellular signalling and gene expression, and implicate miR-199b as a therapeutic target in heart failure.
Collapse
Affiliation(s)
- Paula A da Costa Martins
- Hubrecht Institute, Royal Netherlands Academy of Sciences, PO Box 85164, Utrecht, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|